Search
Trevi Therapeutics Inc
TRVIAdd to Watchlist
15.890USD
-0.010-0.06%
Close 09-14 16:00（ET）
2.26BMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-0.06%
5 Days
-7.94%
1 Month
-12.45%
6 Months
+44.32%
Year to Date
+26.92%
1 Year
+92.61%
Key Figures
16.000Open
16.130High
93.44KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.07%Turnover Ratio
15.900Prev. Close
15.830Low
1.49MTurnover
LossP/E Static
7.04P/B
0.00%Div Yield TTM
-31.83%ROA
20.22052wk High
0.07Volume Ratio
-47.91MNet Profit
142.42MShares
-0.3200EPS TTM
1.06Beta
-33.59%ROE
7.64552wk Low
1.89%Amplitude
--Gross Margin
2.26BMarket Cap
2.54Reward/Risk
3.65%Risk Rate
Analyst Rating
Trevi Therapeutics Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.11/-0.11
Revenue / Forecast
--/0.00
Trevi Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolTRVI
Number of employees26
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| New Enterprise Associates (NEA) | 9.31% |
| Frazier Life Sciences Management, L.P. | 7.23% |
| BlackRock Institutional Trust Company, N.A. | 5.68% |
| Fidelity Management & Research Company LLC | 4.58% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 34.94% |
| Investment Advisor/Hedge Fund | 21.93% |
| Venture Capital | 14.98% |
| Hedge Fund | 11.20% |
Related Instruments
+2.02%
+0.28%
+2.25%
+1.81%
+0.64%
+1.33%
+1.10%
+1.87%
0.00%
+0.88%
+0.79%
+0.72%
+3.34%
+1.31%
+3.99%
+1.57%
+0.62%
+1.86%
+1.89%
+0.14%
FAQs
What is the current price of Trevi Therapeutics Inc (TRVI)?
The current price of Trevi Therapeutics Inc (TRVI) is 15.90.
What is the symbol of Trevi Therapeutics Inc?
The ticker symbol of Trevi Therapeutics Inc is TRVI.
What is the 52-week high of Trevi Therapeutics Inc?
The 52-week high of Trevi Therapeutics Inc is 20.22.
What is the 52-week low of Trevi Therapeutics Inc?
The 52-week low of Trevi Therapeutics Inc is 7.64.
What is the market capitalization of Trevi Therapeutics Inc?
The market capitalization of Trevi Therapeutics Inc is 2.27B.
Is Trevi Therapeutics Inc (TRVI) currently rated as Buy, Hold, or Sell?
According to analysts, Trevi Therapeutics Inc (TRVI) has an overall rating of Buy, with a price target of 29.50.
What is the Earnings Per Share (EPS TTM) of Trevi Therapeutics Inc (TRVI)?
The Earnings Per Share (EPS TTM) of Trevi Therapeutics Inc (TRVI) is -0.32.